Kim Hyun-Young, Kim Hee-Jin, Kim Sun-Hee
Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Blood Res. 2022 Apr 30;57(S1):86-92. doi: 10.5045/br.2022.2022056.
Inherited bone marrow failure syndrome (IBMFS) is a group of clinically heterogeneous disorders characterized by significant hematological cytopenias of one or more hematopoietic cell lineages and is associated with an increased risk of cancer. The genetic etiology of IBMFS includes germline mutations impacting several key biological processes, such as DNA repair, telomere biology, and ribosome biogenesis, which may cause four major syndromes: Fanconi anemia, dyskeratosis congenita, Diamond-Blackfan anemia, and Shwachman-Diamond syndrome. Although the clinical features of some patients may be typical of a particular IBMFS, overlapping and atypical clinical manifestations and variable penetrance pose diagnostic challenges. Here, we review the clinical and genetic features of the major forms of IBMFS and discuss their molecular genetic diagnosis. Next-generation sequencing-based gene panel testing or whole exome sequencing will help elucidate the genetic causes and underlying mechanisms of this genetically heterogeneous group of diseases.
遗传性骨髓衰竭综合征(IBMFS)是一组临床异质性疾病,其特征为一个或多个造血细胞谱系出现显著血细胞减少,并伴有癌症风险增加。IBMFS的遗传病因包括影响DNA修复、端粒生物学和核糖体生物发生等几个关键生物学过程的种系突变,这些突变可能导致四种主要综合征:范可尼贫血、先天性角化不良、先天性纯红细胞再生障碍性贫血和施-戴综合征。尽管一些患者的临床特征可能是特定IBMFS的典型表现,但重叠和非典型临床表现以及可变外显率给诊断带来了挑战。在此,我们回顾了IBMFS主要类型的临床和遗传特征,并讨论了它们的分子遗传学诊断。基于新一代测序的基因panel检测或全外显子组测序将有助于阐明这一基因异质性疾病群体的遗传原因和潜在机制。